Skip to main navigation Skip to search Skip to main content

Cancer: A disease at the crossroads of trade-offs

  • Camille Jacqueline
  • , Peter A Biro
  • , Christa Beckmann
  • , Anders Pape Moller
  • , Francois Renaud
  • , Gabriele Sorci
  • , Aurelie Tasiemski
  • , Beata Ujvari
  • , Frederic Thomas

Research output: Contribution to journalArticlepeer-review

58 Citations (Scopus)

Abstract

Central to evolutionary theory is the idea that living organisms face phenotypic and/or genetic trade-offs when allocating resources to competing life-history demands, such as growth, survival, and reproduction. These trade-offs are increasingly considered to be crucial to further our understanding of cancer. First, evidences suggest that neoplastic cells, as any living entities subject to natural selection, are governed by trade-offs such as between survival and proliferation. Second, selection might also have shaped trade-offs at the organismal level, especially regarding protective mechanisms against cancer. Cancer can also emerge as a consequence of additional trade-offs in organisms (e.g., eco-immunological trade-offs). Here, we review the wide range of trade-offs that occur at different scales and their relevance for understanding cancer dynamics. We also discuss how acknowledging these phenomena, in light of human evolutionary history, may suggest new guidelines for preventive and therapeutic strategies.
Original languageEnglish
Pages (from-to)215-225
JournalEvolutionary Applications
Volume10
Issue number3
DOIs
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 13 - Climate Action
    SDG 13 Climate Action

Keywords

  • Life Histories
  • Host-Parasite Interactions

Fingerprint

Dive into the research topics of 'Cancer: A disease at the crossroads of trade-offs'. Together they form a unique fingerprint.

Cite this